CHRM3 and neoplasm: Tumor measurements revealed 28 and 74% reduction, respectively, in tumor number and size for Chrm3-/- compared to WT mice (P < 0.05 and P < 0.005, respectively) (Figure 2B and C), consistent with our previous work [19].